XML 41 R27.htm IDEA: XBRL DOCUMENT v3.26.3
Significant Accounting Policies (Tables)
6 Months Ended
Sep. 30, 2026
Accounting Policies [Abstract]  
Schedule of income tax expense (benefit)
The following table presents income tax expense (benefit) for the periods indicated:
Three Months Ended September 30,Six Months Ended September 30,
2026202520262025
(in thousands)
Current income tax expense:
State$208 $148 $253 $459 
Foreign41 — 41 35 
Total249 148 294 494 
Deferred income tax benefit:
Federal(62)(209)(406)(737)
Total(62)(209)(406)(737)
Income tax expense (benefit)$187 $(61)$(112)$(243)
Amounts in the table above do not include income tax expense (benefit) related to our refined products and biodiesel businesses, as these amounts have been classified within discontinued operations within our unaudited condensed consolidated statements of operations (see Note 15).
Schedule of inventories
Inventories consist of the following at the dates indicated:
September 30, 2026March 31, 2026
(in thousands)
Butane$47,331 $26,200 
Crude oil24,271 25,173 
Propane12,006 7,320 
Other15,269 8,658 
Total$98,877 $67,351 
Schedule of other noncurrent assets
Other noncurrent assets consist of the following at the dates indicated:
September 30, 2026March 31, 2026
(in thousands)
Costs to obtain contracts with customers (1)
$20,865 $27,183 
Other8,838 12,717 
Total$29,703 $39,900 
(1)    Represents the noncurrent portion of costs to obtain contracts with customers. At September 30, 2026 and March 31, 2026, the costs to obtain contracts with customers was $25.0 million and $27.2 million, respectively, of which $4.1 million is recorded within prepaid expenses and other current assets in our consolidated balance sheet at September 30, 2026.
Schedule of accrued expenses and other payables
Accrued expenses and other payables consist of the following at the dates indicated:
September 30, 2026March 31, 2026
(in thousands)
Derivative liabilities$31,834 $31,619 
Accrued interest27,419 27,265 
Accrued compensation and benefits22,167 75,243 
Distributions payable18,878 18,753 
Excise and other tax liabilities9,582 13,750 
Other53,423 17,554 
Total$163,303 $184,184 
Schedule of variable interest entities
The following table summarizes the balances related to the VIEs that are consolidated in our unaudited condensed consolidated balance sheets at the dates indicated (excluding intercompany eliminations at the time of consolidation) as well as our equity in the VIEs:
September 30, 2026March 31, 2026
(in thousands)
Cash and cash equivalents$40 $96 
Accounts receivable, net29 — 
Accounts receivable-affiliates450 312 
Prepaid expenses and other current assets318 281 
Property, plant and equipment, net15,215 15,527 
Accounts payable(78)(45)
Accrued expenses and other payables(177)(225)
Current maturities of long-term debt(2,038)(1,957)
Long-term debt, net(6,832)(7,867)
Redeemable noncontrolling interests(617)(559)
Partnership's equity in VIEs$6,310 $5,563 
Schedule of redeemable noncontrolling interests The following table summarizes changes in our redeemable noncontrolling interests in our unaudited condensed consolidated balance sheets (in thousands):
Redeemable noncontrolling interests at March 31, 2026$559 
Contributions from redeemable noncontrolling interest owners121 
Net loss from continuing operations attributable to redeemable noncontrolling interests(63)
Redeemable noncontrolling interests at September 30, 2026$617 
Schedule of contingent consideration liabilities
The following table summarizes changes in our contingent consideration liabilities (in thousands):
Contingent consideration liabilities at March 31, 2026 (1)$18,000 
Liabilities settled(1,048)
Contingent consideration liabilities at September 30, 2026 (2)$16,952 
(1)    Includes $2.2 million which is recorded within accrued expenses and other payables and $15.8 million which is recorded within other noncurrent liabilities in our March 31, 2026 consolidated balance sheet.
(2)    Includes $2.2 million which is recorded within accrued expenses and other payables and $14.8 million which is recorded within other noncurrent liabilities in our September 30, 2026 unaudited condensed consolidated balance sheet.